LifeTech Capital Recommends NovaBay Pharmaceuticals

NovaBay of Emeryville, Calif., develops antimicrobial products for a variety of infections, including conjunctivitis, MRSA, the skin disease impetigo, and urinary tract infections.

Read more »

Sinus Patients May Benefit from Surgery, Study Finds

A new study by Oregon Health and Science University indicates that minimally invasive surgery can significantly benefit adults with chronic sinusitis.

Read more »

Diabetes Drug Wins Approval, Helps the Competition

The approval of Novo Nordisk’s diabetes drug Victoza has led to an unintended benefit for a competitor.

Read more »

ImmunoCellular Therapeutics at the 2010 OneMedForum

Manish Singh, President and CEO of ImmunoCellular Therapeutics, discusses his company with William Dawson of LifeTech Capital at the 2010 […]

Read more »

Sword Diagnostics at the 2010 OneMedForum

David Dingott, President and Founder of Sword Diagnostics, Inc., discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 […]

Read more »

Cleveland BioLabs at the 2010 OneMedForum

Michael Fonstein, President and CEO of Cleveland BioLabs, discusses his company with William Dawson of LifeTech Capital at the 2010 […]

Read more »

Facet Solutions at the 2010 OneMedForum

Geoff Pardo, President and CEO of Facet Solutions, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum […]

Read more »

Immunomic Therapeutics at the 2010 OneMedForum

Dr. William G. Hearl, CEO of Immunomic Therapeutics, discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum […]

Read more »

Clarient, Inc. at the 2010 OneMedForum

Ron Andrews, CEO of Clarient, Inc., discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in […]

Read more »

Strategic Medicine at the 2010 OneMedForum

Michael N. Liebman, President and Managing Director of Strategic Medicine, discusses his company with OneMedTV correspondent Alicia Ontiveros at the […]

Read more »